(Q45054030)

9 December 2017

title

Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma (English)

1 reference

9 December 2017

1 reference

6

Tasuku Honjo

1 reference

9 December 2017

Kenji Kabashima

2

0 references

Yoshiki Tokura

8

object named as

Yoshiki Tokura

1 reference

9 December 2017

Ryosuke Hino

1

1 reference

9 December 2017

Yu Kato

3

1 reference

9 December 2017

Hiroaki Yagi

4

1 reference

9 December 2017

Motonobu Nakamura

5

1 reference

9 December 2017

Taku Okazaki

7

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

9 December 2017

1 reference

9 December 2017

volume

116

1 reference

9 December 2017

issue

7

1 reference

9 December 2017

page(s)

1757-1766

1 reference

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

Therapeutic vaccination for the treatment of malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Immunity to melanoma antigens: from self-tolerance to immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Immunosuppression in melanoma immunotherapy: potential opportunities for intervention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

The PD-1-PD-L pathway in immunological tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Significance of B7-H1 overexpression in kidney cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24899

7 January 2021

Identifiers

DOI

10.1002/CNCR.24899

1 reference

9 December 2017

1 reference